Clinical outcomes in a contemporary series of “young” patients with castration-resistant prostate cancer who were 60 years and younger

The findings of this first study of clinical outcomes in a contemporary series of younger patients with mCRPC showed that their survival is similar to that expected in unselected patients with mCRPC who were of any age.